본문으로 건너뛰기
← 뒤로

[Immunotherapy of cutaneous neoplasms].

1/5 보강
Magyar onkologia 📖 저널 OA 4.5% 2024: 0/1 OA 2025: 1/13 OA 2026: 0/6 OA 2024~2026 2025 Vol.69(4) p. 435-440
출처

Ambrus L, Balatoni T

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Skin cancers are the most commonly diagnosed malignancies worldwide; however, effective treatment of advanced tumors was unavailable until recent years.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Ambrus L, Balatoni T (2025). [Immunotherapy of cutaneous neoplasms].. Magyar onkologia, 69(4), 435-440.
MLA Ambrus L, et al.. "[Immunotherapy of cutaneous neoplasms].." Magyar onkologia, vol. 69, no. 4, 2025, pp. 435-440.
PMID 41385766 ↗

Abstract

Skin cancers are the most commonly diagnosed malignancies worldwide; however, effective treatment of advanced tumors was unavailable until recent years. In the past decade, the introduction of immune checkpoint inhibitors (ICIs), targeting CTLA-4, PD-1, PD-L1 and recently LAG-3, has revolutionized therapeutic strategies for advanced skin cancers and improved survival outcomes. In this review, we present the current therapeutic opportunities and future directions of immunotherapy in the management of malignant melanoma, cutaneous squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma, accompanied by a brief overview of their mechanisms of action. Ambrus L, Balatoni T. Immunotherapy of cutaneous neoplasms.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반